alexa Idiopathic Thrombocytopenic Purpura
ISSN: 2155-9864

Journal of Blood Disorders & Transfusion
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

International Conference on Hematology & Blood Disorders
September 23-25, 2013 DoubleTree by Hilton Hotel Raleigh-Durham Airport at RTP, NC, USA

V. Satya Suresh Attili
ScientificTracks Abstracts: J Blood Disord Transfus
DOI: 10.4172/2155-9864.S1.002
Abstract
Idiopathic Thrombocytopenic Purpura (ITP) mostly responds well to steroids. Steroid refractory ITP, though not so common, forms a major challenge in the regular practice of hematologists, more so in developing nations in view of cost and expertise constraints. While most of them agree and adopt spleenectomy as their choice, the induction therapy to shoot the platelets to optimal levels still remains varies among the practitioners. Though options like Intravenous Immunoglobulin (IV Ig), rituximab are standard and known to cause rapid, predictable and usually short lived raise in platelet counts, their use is limited by the costs. Alternatives like Anti-D and vincristine, were also been tried with varied success. This review of hospital records is an attempt to retrospectively look into the practice patterns and the cost-effective analyses of the top four modalities used prior to spleenectomy and present a summary. The average results suggest that in patients, who don?t have life threatening disease, vincristine is still one of the excellent options and the results are comparable with the other standard treatments. However in case of need for rapid response, Anti- D still remains good option in Rh+ cases, as it is more cost effective than IV Ig or rituximab before spleenectomy. However due to non uniformity of adverse event reporting the later though was performed, not reported in the abstract.
image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords